Mirum Pharmaceuticals Quote - MIRM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

52.45

Bid

49.11

Ask

53.58

Volume

940,110

52.05 Day's Range 54.234

23.14 52 Week Range 53.755

Market Cap

2.518B

Previous Close

53.16

Open

53.56

Last Trade

52.6

Last Trade Time

16:04:27

Financial Volume

US$ 49,624,043

VWAP

52.7854

Average Volume (3m)

456,047

Shares Outstanding

48,004,582

Dividend Yield

PE Ratio

-15.41

Earnings Per Share (EPS)

-3.4

Revenue

186.37M

Net Profit

-163.42M

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC... Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Headquarters

Dover, Delaware, USA

Founded

Mirum Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MIRM. The last closing price for Mirum Pharmaceuticals was US$53.16. Over the last year, Mirum Pharmaceuticals shares have traded in a share price range of US$ 23.14 to US$ 53.755.

Mirum Pharmaceuticals currently has 48,004,582 shares outstanding. The market capitalization of Mirum Pharmaceuticals is US$2.55 billion. Mirum Pharmaceuticals has a price to earnings ratio (PE ratio) of -15.41.

Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call on February 26, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will report fourth quarter and year-end 2024 financial results on Wednesday...

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on February 10, 2025, the Compensation Committee of Mirum’s Board of Directors...

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates

- 2024 net product sales of approximately $336 million exceeds upper end of guidance range; preliminary and unaudited estimate - 2025 expected...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.43	2.80282242258	51.02	53.755	49.48	578083	52.21285862	CS
4	4.12	8.52472584316	48.33	53.755	47.39	525376	50.28905226	CS
12	5.89	12.6503436426	46.56	53.755	40.03	456047	46.22797071	CS
26	11.47	27.9892630551	40.98	53.755	36.8591	412175	43.55794527	CS
52	23.49	81.111878453	28.96	53.755	23.14	512660	36.17020404	CS
156	29.64	129.943007453	22.81	53.755	17.315	458092	29.67767155	CS
260	35.27	205.29685681	17.18	53.755	9.14	323395	27.86390597	CS

MIRM - Frequently Asked Questions (FAQ)

What is the current Mirum Pharmaceuticals share price?

The current share price of Mirum Pharmaceuticals is US$ 52.45

How many Mirum Pharmaceuticals shares are in issue?

Mirum Pharmaceuticals has 48,004,582 shares in issue

What is the market cap of Mirum Pharmaceuticals?

The market capitalisation of Mirum Pharmaceuticals is USD 2.55B

What is the 1 year trading range for Mirum Pharmaceuticals share price?

Mirum Pharmaceuticals has traded in the range of US$ 23.14 to US$ 53.755 during the past year

What is the PE ratio of Mirum Pharmaceuticals?

The price to earnings ratio of Mirum Pharmaceuticals is -15.41

What is the cash to sales ratio of Mirum Pharmaceuticals?

The cash to sales ratio of Mirum Pharmaceuticals is 13.51

What is the reporting currency for Mirum Pharmaceuticals?

Mirum Pharmaceuticals reports financial results in USD

What is the latest annual turnover for Mirum Pharmaceuticals?

The latest annual turnover of Mirum Pharmaceuticals is USD 186.37M

What is the latest annual profit for Mirum Pharmaceuticals?

The latest annual profit of Mirum Pharmaceuticals is USD -163.42M

What is the registered address of Mirum Pharmaceuticals?

The registered address for Mirum Pharmaceuticals is 838 WALKER ROAD, SUITE 21-2, DOVER, DELAWARE, 19904

Which industry sector does Mirum Pharmaceuticals operate in?

Mirum Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
RETOReTo Eco Solutions Inc	US$ 1.69 (316.36%)	22.86M
GSUNGolden Sun Health Technology Group Ltd	US$ 4.19 (58.11%)	592.97k
CNEYCN Energy Group Inc	US$ 0.3185 (30.21%)	10.2M
ORISOriental Rise Holdings Ltd	US$ 1.42 (26.79%)	690.77k
CCTGCCSC Technology International Holdings Ltd	US$ 2.13 (25.29%)	35.84k
BOXLBoxlight Corporation	US$ 2.57 (-17.10%)	535.74k
BOWNBowen Acquisition Corporation	US$ 3.2799 (-13.23%)	1.13k
NKLANikola Corporation	US$ 0.3315 (-12.76%)	2.77M
CHSNChanson International Holding	US$ 0.321 (-12.39%)	7.08M
BMRABiomerica Inc	US$ 0.7601 (-9.40%)	38.47k
RETOReTo Eco Solutions Inc	US$ 1.69 (316.36%)	22.86M
CNEYCN Energy Group Inc	US$ 0.3185 (30.21%)	10.2M
ADTXAditxt Inc	US$ 0.091 (-0.55%)	8.63M
DGLYDigital Ally Inc	US$ 0.0836 (1.33%)	7.47M
MLGOMicroAlgo Inc	US$ 5.90 (-7.23%)	7.16M